Login
$CMPS
$11.81 +$0.76 (6.88%) Close

$CMPS 3 SEC Filings

Filed On Filing
29 May 2026 Form 3: Tregoning Kathleen, Director

No securities owned

31 Oct 2025 Form 3: Jonas Jeffrey M, Director

No securities owned

30 Jul 2025 Form 3: Gover Justin D., Director

No securities owned

04 Sep 2024 Form 3: Santini Gino, Director

No securities owned

05 Mar 2024 Form 3: Loxam Teri, Chief Financial Officer

No securities owned

27 Oct 2023 Form 3: Hughes Mary-Rose, Interim CFO

Holds 1,232 shares of Ordinary Shares

20 Sep 2023 Form 3: Karydas Daphne, Director

No securities owned

03 Aug 2022 Form 3: Nath Kabir, Director

No securities owned

28 Feb 2022 Form 3: Atai Life Sciences N.v., 10% owner and 1 other

Holds 9,565,774 shares of Ordinary Shares

15 Feb 2022 Form 3: Owens Matthew A, General Counsel & CLO

No securities owned

03 Jan 2022 Form 3: Falvey Michael, Chief Financial Officer
03 Jan 2022 Form 3: Goldsmith George Jay, Director

Holds 4,261,573 shares of Ordinary Shares

03 Jan 2022 Form 3: Lonngren Thomas, Director

Holds 89,049 shares of Ordinary Shares

03 Jan 2022 Form 3: Norton David Y, Director

Holds 23,740 shares of Ordinary Shares

03 Jan 2022 Form 3: Jenkins Annalisa, Director

Holds 23,740 shares of Ordinary Shares

03 Jan 2022 Form 3: McQuade Robert, Director
03 Jan 2022 Form 3: Camm Jason, Director

No securities owned

03 Jan 2022 Form 3: Malievskaia Ekaterina, Chief Innovation Officer

Holds 4,261,569 shares of Ordinary Shares

03 Jan 2022 Form 3: Goodwin Guy, Chief Medical Officer
03 Jan 2022 Form 3: Riley Wayne Joseph, Director

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support